Entheon Biomedical Corp. (ENTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0790
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Entheon Biomedical Employees
Entheon Biomedical had 1 employees as of August 31, 2025. The number of employees did not change compared to the same quarter last year.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$249,530
Market Cap
1.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 1 | 0 | - |
| May 31, 2025 | 1 | 0 | - |
| Nov 30, 2024 | 1 | -1 | -50.00% |
| Aug 31, 2024 | 1 | -1 | -50.00% |
| May 31, 2024 | 1 | -1 | -50.00% |
| Feb 29, 2024 | 1 | -1 | -50.00% |
| Nov 30, 2023 | 2 | 0 | - |
| Aug 31, 2023 | 2 | -1 | -33.33% |
| May 31, 2023 | 2 | -2 | -50.00% |
| Feb 28, 2023 | 2 | -2 | -50.00% |
| Nov 30, 2022 | 2 | -2 | -50.00% |
| Aug 31, 2022 | 3 | -1 | -25.00% |
| May 31, 2022 | 4 | 0 | - |
| Feb 28, 2022 | 4 | 1 | 33.33% |
| Aug 31, 2021 | 4 | 1 | 33.33% |
| May 31, 2021 | 4 | 1 | 33.33% |
| Feb 28, 2021 | 3 | - | - |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Emmaus Life Sciences | 35 |
| Evofem Biosciences | 32 |
| International Stem Cell | 32 |
| CERo Therapeutics Holdings | 8 |
| Lipella Pharmaceuticals | 7 |
| Sigyn Therapeutics | 4 |
Entheon Biomedical News
- 24 days ago - Entheon Announces Execution of Business Combination Agreement with Nutravisor - Newsfile Corp
- 7 weeks ago - Entheon Announces Letter of Intent with Nutravisor Inc. - Newsfile Corp
- 11 months ago - Entheon Announces Change of Directors - Newsfile Corp
- 11 months ago - Entheon Issues Incentive Stock Options - Newsfile Corp
- 11 months ago - Entheon Announces Termination of Mentis AI Agreement - Newsfile Corp
- 1 year ago - Entheon Announces Agreement to Acquire Mentis AI - Newsfile Corp
- 3 years ago - Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets - Newsfile Corp
- 4 years ago - Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents - Newsfile Corp